Adaptyx Biosciences, developer of a biowearable device to help manage illness and treatment, raised a $14 million seed round, co-founder and CEO Vijit Sabnis tells Axios Pro exclusively.
Why it matters: The startup could begin fundraising again next year as it works to secure FDA approval for its device.
